Potential of the Stromal Matricellular Protein Periostin as a Biomarker to Improve Risk Assessment in Prostate Cancer

Prostate cancer (PCa) ranges from indolent to aggressive tumors that may rapidly progress and metastasize. The switch to aggressive PCa is fostered by reactive stroma infiltrating tumor foci. Therefore, reactive stroma-based biomarkers may potentially improve the early detection of aggressive PCa, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Doldi, Valentina, Lecchi, Mara, Ljevar, Silva, Colecchia, Maurizio, Campi, Elisa, Centonze, Giovanni, Marenghi, Cristina, Rancati, Tiziana, Miceli, Rosalba, Verderio, Paolo, Valdagni, Riccardo, Gandellini, Paolo, Zaffaroni, Nadia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324424/
https://www.ncbi.nlm.nih.gov/pubmed/35887333
http://dx.doi.org/10.3390/ijms23147987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324424/
https://www.ncbi.nlm.nih.gov/pubmed/35887333
http://dx.doi.org/10.3390/ijms23147987

Ejemplares similares